The use of CRISR/Cas9 revealed that inhibition of the RBM39 protein leads to mis-splicing of Homeobox A Cluster (HOXA9) target genes, which constitute a network essential for AML survival (43). The gene discussed is HOXA9; the disease is acute myeloid leukemia.